Breaking News Instant updates and real-time market news.

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

, ADI

Analog Devices

$87.50

-0.57 (-0.65%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alkermes (ALKS) downgraded to Sell from Neutral at Goldman Sachs with analyst Terence Flynn saying he removed sales of ALKS 5461 for depression from his model as well as the "M&A component" from his price target. He now sees 21% downside to his price target. 2. Analog Devices (ADI) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Craig Hettenbach saying while the company's guidance was "well ahead of peers", he sees it hard to remain positive on the stock considering the ongoing risks to semis in 2019. 3. Under Armour (UA, UAA) downgraded to Underweight from Neutral at Atlantic Equities. 4. Micron (MU) downgraded to Hold from Buy at Needham and to Sector Perform from Outperform at RBC Capital. 5. JPMorgan (JPM) downgraded to Neutral from Overweight at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ALKS

Alkermes

$31.58

-0.25 (-0.79%)

ADI

Analog Devices

$87.50

-0.57 (-0.65%)

UAA

Under Armour

$18.63

-0.18 (-0.96%)

UA

Under Armour

$17.21

-0.18 (-1.04%)

MU

Micron

$33.30

-0.82 (-2.40%)

JPM

JPMorgan

$99.31

0.79 (0.80%)

  • 07

    Jan

  • 08

    Jan

  • 08

    Jan

  • 31

    Jan

  • 26

    Feb

  • 03

    Mar

ALKS Alkermes
$31.58

-0.25 (-0.79%)

12/18/18
GSCO
12/18/18
DOWNGRADE
Target $26
GSCO
Sell
Goldman downgrades Alkermes to Sell ahead of potential schizophrenia launch
Goldman Sachs analyst Terence Flynn downgraded Alkermes to Sell from Neutral and lowered his price target for the shares to $26 from $49. The drugmaker closed the trading day down 3%, or $1.13, to $31.82. The analyst downgraded the shares after removing sales of ALKS 5461 for depression from his model as well as the "M&A component" from his price target. He now sees 21% downside to his price target. Recent channel checks suggest the current profile of ALKS 3831 for schizophrenia, based on weight gain alone, is unlikely to be "practice changing," Flynn tells investors in a research note. Further, the checks suggest that the metabolic data is viewed as equally if not more important than the weight data. He also believes Alkermes' level of investment ahead of a potential ALKS 3831 launch is underappreciated. On depression drug ALKS 5461, Flynn expects the FDA to issue a complete response letter on or before the January 31 action date. The analyst does not expect Study 217 to be sufficient to address potential FDA issues following the negative panel outcome.
12/18/18
GSCO
12/18/18
DOWNGRADE
GSCO
Sell
Alkermes downgraded to Sell from Neutral at Goldman Sachs
12/17/18
PIPR
12/17/18
NO CHANGE
PIPR
Overweight
Piper says Biogen's diroximel fumarate opportunity being largely overlooked
After Biogen (BIIB) announced the submission of an NDA for diroximel fumarate, or BIIB098, Piper Jaffray analyst Christopher Raymond said he thinks investor sentiment largely overlooks the opportunity and that many discount it as "a Tecfidera IP play." However, he thinks BIIB098 could be "a pretty big deal" for Biogen's MS business as he believes the side effect profile improves measurably upon that of Tecfidera. Raymond, who contends that approval of this agent, which he notes is in-licensed from Alkermes (ALKS), could meaningfully reinvigorate Biogen's oral fumarate franchise, keeps an Overweight rating on Biogen shares.
12/14/18
WOLF
12/14/18
INITIATION
WOLF
Underperform
Alkermes initiated with an Underperform at Wolfe Research
ADI Analog Devices
$87.50

-0.57 (-0.65%)

12/18/18
MSCO
12/18/18
DOWNGRADE
Target $100
MSCO
Equal Weight
Analog Devices downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Craig Hettenbach downgraded Analog Devices to Equal Weight from Overweight with a price target of $100. The analyst notes that while the company's guidance was "well ahead of peers", he sees it hard to remain positive on the stock considering the ongoing risks to semis in 2019. Hettenbach contends that Analog Devices should remain a "core long-term holding", but believes that its "elevated" estimates will make near term outperformance "difficult".
11/21/18
RHCO
11/21/18
NO CHANGE
Target $106
RHCO
Buy
Analog Devices price target lowered to $106 from $118 at SunTrust
SunTrust analyst William Stein lowered his price target on Analog Devices to $106 to reflect the lower multiples of the broader semiconductors sector. The analyst keeps his Buy rating however and recommends that investors buy the stock ahead of "normalizing valuation" and potential for M&A benefits. Stein also believes that Analog Devices is navigating the trade tariff concerns "better than most peers owing to its strong position in comms and ongoing benefits from HITT and LLTC that are becoming more evident". The analyst anticipates the company outperforming in 2019 thanks to its lower than expected leverage and higher cost savings along with the industry's improving demand.
11/21/18
LOOP
11/21/18
NO CHANGE
Target $102
LOOP
Buy
Analog Devices price target lowered to $102 from $117 at Loop Capital
Loop Capital analyst Cody Acree lowered his price target on Analog Devices to $102 to reflect the broader industry multiple contraction, modelling an 18-times forward earnings multiple and a FY20 EPS of $5.54. The analyst also keeps his Buy rating after the company's Q4 earnings beat, saying the quarter was "not as bad as feared", adding that investors' positive reaction to the print "may signal an increased interest to move money back into semiconductors". Acree still maintains a somewhat cautious view based on Analog Devices' "commentary regarding tariff-related inflationary pressure, particularly in the industrial and automotive markets, which have been among the largest drivers of growth for the chip industry over the past few years."
UAA Under Armour
$18.63

-0.18 (-0.96%)

12/19/18
ATLE
12/19/18
DOWNGRADE
ATLE
Underweight
Under Armour downgraded to Underweight from Neutral at Atlantic Equities
12/13/18
DBAB
12/13/18
NO CHANGE
Target $19
DBAB
Hold
Both bulls and bears got talking points from Under Armour, says Deutsche Bank
In a research note titled "Glass Half Empty vs. Half Full," Deutsche Bank analyst Paul Trussell says Under Armour's investor day provided both bears and bulls with talking points. From a pessimistic perspective, the stock had clearly priced in more aggressive targets, especially for fiscal 2019, and valuation looks "fair to still expensive punching in the long-term outlook," Trussell writes. On the other hand, though, the analyst points that Under Armour raised its Q4 forecast, provided fiscal 2019 guidance that "looks quite achievable given modest expectations for margin recapture and no acceleration in top-line sequentially." He lowered his price target for the shares to $19 from $20 and keeps a Hold rating on the name.
12/13/18
MSCO
12/13/18
NO CHANGE
Target $21
MSCO
Equal Weight
Under Armour guidance conservative, but investors cautious, says Morgan Stanley
Morgan Stanley analyst Lauren Cassel called Under Armour's 2019 guidance "appropriately conservative," but she believes the company needs to show investors next year's numbers are achievable before they put faith in the company's 5-year targets, which "met elevated expectations." Following the company's investor day, Cassel raised her out-year estimates by about 30%, on average, but keeps a $21 price target and Equal Weight rating on Under Armour, which she still considers a "show me" story.
12/13/18
JEFF
12/13/18
NO CHANGE
Target $28
JEFF
Buy
Under Armour five-year outlook back-end loaded, says Jefferies
Jefferies analyst Randal Konik says Under Armour yesterday gave a "thorough deep dive" that showed a path to better North American growth, "massive" international potential and "substantially" better product. That said, the company's five-year outlook is back-end loaded, which means the turnaround will take time, Konik tells investors in research note following the company's analyst day. Konik, while confident that Under Armour's improvements will occur and management's guidance is conservative, lowered his price target for the shares to $28 from $30. He keeps a Buy rating on the name.
UA Under Armour
$17.21

-0.18 (-1.04%)

12/13/18
PIPR
12/13/18
NO CHANGE
Target $32
PIPR
Overweight
Under Armour five-year plan 'not a stretch,' says Piper Jaffray
Piper Jaffray analyst Erinn Murphy remains positive on Under Armour shares following yesterday's investor day. The analyst sees the company's five-year plan as "thoughtful but not a stretch." The new product previewed will hit the market starting in Q2 and footwear is a key multi-year growth driver, Murphy tells investors in a research note. She keeps an Overweight rating on Under Armour with a $32 price target.
MU Micron
$33.30

-0.82 (-2.40%)

12/19/18
RBCM
12/19/18
DOWNGRADE
Target $40
RBCM
Sector Perform
Micron downgraded to Sector Perform at RBC Capital on inventory, demand risks
As reported earlier, RBC Capital analyst Amit Daryanani downgraded Micron to Sector Perform from Outperform and lowered his price target to $40 from $59 after its disappointing Q2 outlook. The analyst cites the company's inventory risk, as the "ongoing" industry downturn has increased its inventories by 22% "and heading higher" in the February quarter, warning that memory also tends to be a "depreciating asset" as the industry correction gets more "severe". Daryanani is also concerned with "Demand risk" for Micron, with real possibility that the issue requires further reduction in capacity and/or lower pricing in mid-2019. Additionally, the analyst cites competitive risk given the lack of clarity about its peers' intentions to reduce capacity and an upside inflection in Micron's operating expenses, which could pressure earnings further in Q3.
12/19/18
KEYB
12/19/18
NO CHANGE
Target $45
KEYB
Overweight
Micron price target lowered to $45 from $61 at KeyBanc
KeyBanc analyst Weston Twigg lowered his price target for Micron to $45 from $61 after the company reported results in line with its Q1 preannouncement, but offered Q2 guidance well below consensus as customers continue to draw down inventory in the face of softening demand and growing uncertainty into 1H19. Still, the analyst thinks Micron is performing relatively well, with margins likely to hold up better than past cycles. Twigg reiterates an Overweight rating on the shares as he believes in strong, long-term demand drivers and solid execution throughout cycles
12/19/18
LBOW
12/19/18
NO CHANGE
LBOW
Neutral
Micron 'getting close' to a bottom, says Longbow
Longbow analyst Joe Wittine noted that Micron guided February quarter results materially lower, as expected, citing broadly weak end markets, a transition year ahead for SSDs, and falling bit prices for both DRAM and NAND. In a note entitled "Getting Close to the Bottom," Wittine said that the company's estimates for 2019 DRAM and NAND bit growth seem to imply "relatively healthy" August and November quarter bit growth forecasts. He maintains a Neutral rating on Micron shares.
12/19/18
MSCO
12/19/18
NO CHANGE
Target $33
MSCO
Equal Weight
Micron price target lowered to $33 from $48 at Morgan Stanley
Morgan Stanley analyst Joseph Moore said Micron's climbing inventory levels validate his previously expressed undershipment concerns and that inventory has to be cleared out for supply and demand to come into balance. The company's capital spending cuts will help, but fixing the situation will take time, contends Moore, who lowered his price target on Micron shares to $33 from $48 following the company's Q1 report. He maintains an Equal Weight rating on Micron.
JPM JPMorgan
$99.31

0.79 (0.80%)

12/12/18
KBWI
12/12/18
NO CHANGE
KBWI
Keefe downgrades Universal Banks sector to Market Weight from Overweight
Keefe Bruyette analyst Frederick Cannon downgraded his rating on the Universal Banks sector to Market Weight from Overweight. Universal Bank stocks underperformed the broader market this year as loan growth repeatedly disappointed and macroeconomic risks weighed on shares into year-end, Cannon tells investors in a research note. As the analyst looks into 2019, he "does not see enough positive catalysts emerging" that could move the group higher. Cannon says Universal Banks are currently trading at 60% of the S&P 500 based on 2019 consensus earnings estimates, but that relative valuation is not enough to make him stay constructive on the group. His firm last night also downgraded shares of Bank of America (BAC) and Morgan Stanley (MS) to Market Perform from Outperform.
12/07/18
FBCO
12/07/18
NO CHANGE
Target $35
FBCO
Outperform
Bank of America price target cut to $35 from $36 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke maintained a Neutral rating on Bank of America (BAC) but cut her price target to $35 from $36. In a research note to investors, she says that she has increased the weighting on her "gray sky valuation" to 25% from 15% and reduced the weighting on her "blue sky scenario" to 25% from 35%, and while she does not anticipate an imminent turn in the cycle, she feels she must recognize some increased probability relative to the status quo. For Bank of America, she says organic revenue growth, visible operating leverage, manageable credit cost increases and capital efficiency will drive realization of franchise value. The analyst also lowered her price targets on other large banks, including Morgan Stanley (MS), PNC (PNC), State Street (STT), Goldman Sachs (GS), JPMorgan (JPM) and Wells Fargo (WFC).
12/07/18
FBCO
12/07/18
NO CHANGE
Target $146
FBCO
Neutral
PNC Financial price target cut to $146 from $150 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke maintained a Neutral rating on PNC Financial (PNC) but cut her price target to $146 from $150. In a research note to investors, she says that she has increased the weighting on her "gray sky valuation" to 25% from 15% and reduced the weighting on her "blue sky scenario" to 25% from 35%, and while she does not anticipate an imminent turn in the cycle, she feels she must recognize some increased probability relative to the status quo. The analyst also lowered her price targets on other large banks, including Morgan Stanley (MS), Bank of America (BAC), State Street (STT), Goldman Sachs (GS), JPMorgan (JPM) and Wells Fargo (WFC).
12/19/18
ATLE
12/19/18
DOWNGRADE
ATLE
Neutral
JPMorgan downgraded to Neutral from Overweight at Atlantic Equities

TODAY'S FREE FLY STORIES

FB

Facebook

$189.25

5.96 (3.25%)

, V

Visa

$178.66

1.31 (0.74%)

12:58
10/15/19
10/15
12:58
10/15/19
12:58
Periodicals
Facebook advances Libra amid backer mutiny, Business Insider says »

Facebook (FB) took…

FB

Facebook

$189.25

5.96 (3.25%)

V

Visa

$178.66

1.31 (0.74%)

MA

MasterCard

$278.77

2.29 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

12:55
10/15/19
10/15
12:55
10/15/19
12:55
Conference/Events
Morgan Stanley analysts to hold an analyst/industry conference call »

Executive Director of…

APHA

Aphria

$5.40

1.07 (24.71%)

12:51
10/15/19
10/15
12:51
10/15/19
12:51
Recommendations
Aphria analyst commentary  »

Seaport Global says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 12

    Nov

GOOG

Alphabet

$1,240.28

22.05 (1.81%)

, GOOGL

Alphabet Class A

$1,240.59

22.98 (1.89%)

12:44
10/15/19
10/15
12:44
10/15/19
12:44
Hot Stocks
Google Stadia launches on November 19th »

In a tweet, the Google…

GOOG

Alphabet

$1,240.28

22.05 (1.81%)

GOOGL

Alphabet Class A

$1,240.59

22.98 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

GOOG

Alphabet

$1,240.62

22.39 (1.84%)

, GOOGL

Alphabet Class A

$1,241.32

23.71 (1.95%)

12:40
10/15/19
10/15
12:40
10/15/19
12:40
Hot Stocks
Google announces Nest Wifi system »

Alphabet's Google…

GOOG

Alphabet

$1,240.62

22.39 (1.84%)

GOOGL

Alphabet Class A

$1,241.32

23.71 (1.95%)

TGT

Target

$111.99

0.85 (0.76%)

BBY

Best Buy

$68.65

-0.055 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

GOOG

Alphabet

$1,240.95

22.72 (1.87%)

, GOOGL

Alphabet Class A

$1,241.95

24.34 (2.00%)

12:38
10/15/19
10/15
12:38
10/15/19
12:38
Hot Stocks
Google introduces Google Pixel Buds »

Alphabet's Google…

GOOG

Alphabet

$1,240.95

22.72 (1.87%)

GOOGL

Alphabet Class A

$1,241.95

24.34 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

UNH

UnitedHealth

$235.51

15.19 (6.89%)

, CNC

Centene

$45.39

1.49 (3.39%)

12:37
10/15/19
10/15
12:37
10/15/19
12:37
Hot Stocks
Health insurance providers move higher after UnitedHealth Q3 results »

Health insurance…

UNH

UnitedHealth

$235.51

15.19 (6.89%)

CNC

Centene

$45.39

1.49 (3.39%)

ANTM

Anthem

$249.46

14.73 (6.28%)

HUM

Humana

$275.49

11.53 (4.37%)

MOH

Molina Healthcare

$117.98

5.495 (4.89%)

CI

Cigna

$159.78

8.165 (5.39%)

WCG

WellCare

$268.48

5.44 (2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 07

    Nov

  • 13

    Nov

  • 14

    Nov

TGT

Target

$112.03

0.89 (0.80%)

, BBY

Best Buy

$68.72

0.015 (0.02%)

12:36
10/15/19
10/15
12:36
10/15/19
12:36
Hot Stocks
Google announces next-generation Nest Mini »

Alphabet's Google…

TGT

Target

$112.03

0.89 (0.80%)

BBY

Best Buy

$68.72

0.015 (0.02%)

GOOGL

Alphabet Class A

$1,243.00

25.39 (2.09%)

GOOG

Alphabet

$1,242.22

23.99 (1.97%)

WMT

Walmart

$119.12

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 13

    Nov

  • 14

    Nov

BRK.B

Berkshire Hathaway

$209.71

1.86 (0.89%)

, BRK.A

Berkshire Hathaway

$314,700.00

3137 (1.01%)

12:33
10/15/19
10/15
12:33
10/15/19
12:33
Hot Stocks
Bank of America up 4% after Bloomberg says Buffett trying to boost stake »

Shares of Bank of America…

BRK.B

Berkshire Hathaway

$209.71

1.86 (0.89%)

BRK.A

Berkshire Hathaway

$314,700.00

3137 (1.01%)

BAC

Bank of America

$29.90

0.75 (2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

GOOGL

Alphabet Class A

$1,242.63

25.02 (2.05%)

, GOOG

Alphabet

$1,241.65

23.42 (1.92%)

12:32
10/15/19
10/15
12:32
10/15/19
12:32
Hot Stocks
Google officially announces Pixel 4, Pixel 4 XL »

Google officially…

GOOGL

Alphabet Class A

$1,242.63

25.02 (2.05%)

GOOG

Alphabet

$1,241.65

23.42 (1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

BRK.B

Berkshire Hathaway

$209.67

1.82 (0.88%)

, BRK.A

Berkshire Hathaway

$314,700.00

3137 (1.01%)

12:30
10/15/19
10/15
12:30
10/15/19
12:30
Periodicals
Buffett seeks Fed permission to boost Bank of America stake, Bloomberg reports »

Warren Buffett's…

BRK.B

Berkshire Hathaway

$209.67

1.82 (0.88%)

BRK.A

Berkshire Hathaway

$314,700.00

3137 (1.01%)

BAC

Bank of America

$29.89

0.74 (2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

12:30
10/15/19
10/15
12:30
10/15/19
12:30
General news
Breaking General news story  »

Kansas City Federal…

TSLA

Tesla

$258.25

1.35 (0.53%)

12:28
10/15/19
10/15
12:28
10/15/19
12:28
Periodicals
Tesla Model Y production to begin in 1Q20, CleanTechnica says »

Tesla will accelerate its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

DIS

Disney

$130.30

0.61 (0.47%)

, TCEHY

Tencent

$0.00

(0.00%)

12:25
10/15/19
10/15
12:25
10/15/19
12:25
On The Fly
Game On: An exclusive talk with GrabTheGames founder Rafal Kokosza »

GRABTHEGAMES: In an…

DIS

Disney

$130.30

0.61 (0.47%)

TCEHY

Tencent

$0.00

(0.00%)

GOOGL

Alphabet Class A

$1,242.12

24.51 (2.01%)

GOOG

Alphabet

$1,241.14

22.91 (1.88%)

AAPL

Apple

$235.75

-0.12 (-0.05%)

MSFT

Microsoft

$141.41

1.87 (1.34%)

SNE

Sony

$58.50

0.675 (1.17%)

NTDOY

Nintendo

$0.00

(0.00%)

KKR

KKR

$26.78

0.66 (2.53%)

TTWO

Take-Two

$122.75

1.63 (1.35%)

EA

Electronic Arts

$94.28

0.46 (0.49%)

ATVI

Activision Blizzard

$54.70

-0.3 (-0.55%)

UBSFY

Ubisoft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 18

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 21

    Nov

  • 21

    Nov

BCS

Barclays

$8.31

0.41 (5.19%)

12:25
10/15/19
10/15
12:25
10/15/19
12:25
Options
Barclays call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 12

    Nov

12:25
10/15/19
10/15
12:25
10/15/19
12:25
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

JPM

JPMorgan

$121.20

4.81 (4.13%)

, WFC

Wells Fargo

$51.07

1.77 (3.59%)

12:18
10/15/19
10/15
12:18
10/15/19
12:18
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been reacting…

JPM

JPMorgan

$121.20

4.81 (4.13%)

WFC

Wells Fargo

$51.07

1.77 (3.59%)

C

Citi

$71.82

1.54 (2.19%)

GS

Goldman Sachs

$205.30

-0.51 (-0.25%)

JNJ

Johnson & Johnson

$133.31

2.64 (2.02%)

UNH

UnitedHealth

$236.83

16.51 (7.49%)

RETA

Reata Pharmaceuticals

$158.02

57.65 (57.44%)

APHA

Aphria

$5.43

1.1 (25.40%)

PAGS

PagSeguro Digital

$40.53

-5.72 (-12.37%)

WLL

Whiting Petroleum

$6.74

-0.515 (-7.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 27

    Oct

  • 29

    Oct

  • 04

    Nov

  • 06

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 17

    Dec

  • 17

    Oct

TCEHY

Tencent

$0.00

(0.00%)

12:18
10/15/19
10/15
12:18
10/15/19
12:18
Periodicals
Epic Games 'Fortnite' is back, featuring a new map, NYT says »

Niraj Chokshi and Daniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:17
10/15/19
10/15
12:17
10/15/19
12:17
Conference/Events
Peterson Institute for International Economics to hold a discussion »

Patrick Honohan, Peterson…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/15/19
10/15
12:17
10/15/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/15/19
10/15
12:16
10/15/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USFD

US Foods

$40.43

-0.14 (-0.35%)

12:08
10/15/19
10/15
12:08
10/15/19
12:08
Hot Stocks
US Foods announces resignation of chief supply chain officer Tim Connolly »

US Foods Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 12

    Nov

AXP

American Express

$117.86

1.47 (1.26%)

12:05
10/15/19
10/15
12:05
10/15/19
12:05
Hot Stocks
American Express reports September write-off rate 2.0% vs. 2.3% last month »

Reports September 30 days…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 27

    Oct

  • 13

    Nov

  • 06

    Dec

12:05
10/15/19
10/15
12:05
10/15/19
12:05
General news
Treasury's $87 B 3- and 6-month bill offerings were mixed and polar opposites »

Treasury's $87 B 3-…

UNH

UnitedHealth

$237.73

17.41 (7.90%)

12:00
10/15/19
10/15
12:00
10/15/19
12:00
Hot Stocks
UnitedHealth rises 8.0% »

UnitedHealth is up 8.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.